论文信息 - Second-look laparotomy in the patient with minimal residual stage III ovarian cancer (a Gynecologic Oncology Group Study). - 字舞流文

Second-look laparotomy in the patient with minimal residual stage III ovarian cancer (a Gynecologic Oncology Group Study).

R. Mortel | B. Bundy | W. Creasman | H. Homesley | S. Gall | J. Beecham

[1] B. Bundy,et al. Therapy of stage III (optimal) epithelial carcinoma of the ovary with melphalan or melphalan plus corynebacterium parvum (a gynecologic oncology group study) , 1986 .

[2] N. Sneige,et al. Prognosis of surgically determined complete responders in advanced ovarian cancer , 1985, Cancer.

[3] J. Fielding,et al. Second‐Look Laparotomy in the Management of Epithelial Ovarian Carcinoma: An Evaluation of Fifty Cases , 1984, Obstetrics and gynecology.

[4] C. Cohen,et al. Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO Stages III and IV) as measured by surgical end-staging (second-look operation). , 1983, American journal of obstetrics and gynecology.

[5] L. Einhorn,et al. Treatment of advanced epithelial ovarian cancer using cisplatin, adriamycin and cytoxan--the Indiana University experience. , 1983, Clinics in obstetrics and gynaecology.

[6] P. Schwartz,et al. Second-look operations in ovarian cancer. , 1980, American journal of obstetrics and gynecology.

[7] Griffiths Ct. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. , 1975 .

[8] David R. Cox,et al. Regression models and life tables (with discussion , 1972 .

[9] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .